Stay updated on Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page
- CheckyesterdayChange DetectedRevision tag updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedAdded new disease terms (primary peritoneal carcinoma and fallopian tube cancer) and new resources (Genetic and Rare Diseases Information Center; MedlinePlus Genetics). Updated the page revision from v3.4.1 to v3.4.2.SummaryDifference0.2%

- Check45 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; no user-visible changes to study details or page behavior. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedThe explicit 'Ovarian cancer' topic and the 'MedlinePlus Genetics' related topics have been removed.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4, a minor maintenance update with no changes to core study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab+Talazoparib in Untreated Advanced Ovarian Cancer Clinical Trial page.